|
1396 |
기타 간질환 |
그외 간질환 |
2021 |
Personalized Medicine in Liver Disease via Modulating the Gut Microbiota
|
Ki Tae Suk |
|
300 |
|
1395 |
기타 간질환 |
그외 간질환 |
2021 |
Personalized Medicine in Autoimmune Hepatitis
|
Atsumasa Komori |
|
308 |
|
1394 |
기초연구/연구방법론 |
연구방법론 |
2021 |
My Research Interests in the Field of Hepatology and Gastroenterology
|
Jeong-Hoon Lee |
|
247 |
|
1393 |
기초연구/연구방법론 |
연구방법론 |
2021 |
Optimizing the Secondary Prevention of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B: A Lesson from Real-World Evidence
|
Jonggi Choi |
|
318 |
|
1392 |
기초연구/연구방법론 |
연구방법론 |
2021 |
Recent Epidemiology of Hepatocellular Carcinoma in the USA
|
Ju Dong Yang |
|
256 |
|
1391 |
기타 간질환 |
그외 간질환 |
2021 |
Acute-on-Chronic Liver Failure: Achievements and Future Perspectives
|
Shiv Kumar Sarin |
|
287 |
|
1390 |
간경변증 |
간경변증 |
2021 |
Individualized Risk Stratification of Compensated Advanced Chronic Liver Disease (cACLD)
|
Annalisa Berzigotti |
|
421 |
|
1389 |
간종양 |
간세포암 |
2021 |
LI-RADS Classification?and Its Impact on the Prognosis of Primary Liver Cancer
|
Sang Hyun Choi |
|
254 |
|
1388 |
간종양 |
간세포암 |
2021 |
Imaging Phenotype of Hepatocellular Carcinoma Subtypes
|
Jin-Young Choi |
|
237 |
|
1387 |
간종양 |
간세포암 |
2021 |
Different Hepatocellular Carcinoma Risk and Surveillance Strategies According to Situations: Young Age
|
Nae-Yun Heo |
|
246 |
|
1386 |
간종양 |
간세포암 |
2021 |
Different Hepatocellular Carcinoma Risk and Surveillance Strategies According to Situations: After Virologic Cure
|
Jung Hyun Kwon |
|
225 |
|
1385 |
간종양 |
간세포암 |
2021 |
Role of Systemic Therapy in Intermediate-Stage Hepatocellular Carcinoma
|
Masatoshi Kudo |
|
243 |
|
1384 |
간종양 |
간세포암 |
2021 |
Role of Loco-Regional Treatment in Advanced-Stage Hepatocellular Carcinoma
|
Ju Hyun Shim |
|
216 |
|
1383 |
간종양 |
간세포암 |
2021 |
Optimizing Radiotherapy with Immune Checkpoint Blockade in Hepatocellular Carcinoma
|
Jeong Il Yu |
|
214 |
|
1382 |
간종양 |
간세포암 |
2021 |
Treatment of Advanced Hepatocellular Carcinoma with Child-Pugh B Cirrhosis
|
Chang Wook Kim |
|
227 |
|
1381 |
간종양 |
간세포암 |
2021 |
Selecting First-Line Therapy for Advanced Hepatocellular Carcinoma: TKI vs. ICI
|
Kyung-Hun Lee |
|
253 |
|
1380 |
간종양 |
간세포암 |
2021 |
How to Optimize Sequence of Systemic Treatment in Advanced Hepatocellular Carcinoma
|
Ann-Lii Cheng |
|
255 |
|
1379 |
간종양 |
간세포암 |
2021 |
Hepatocellular Carcinoma Patients on Systemic Therapy: Prediction of Prognosis
|
Beom Kyung Kim |
|
227 |
|
1378 |
간종양 |
간세포암 |
2021 |
Assessment of Tumor Response in Patients Receiving Systemic Therapy: RECIST 1.1, Modified RECIST, or Other Options
|
Min-Hee Ryu |
|
335 |
|
1377 |
간종양 |
간세포암 |
2021 |
Expanding Criteria for Liver Transplantation: Sero-Positive Donors
|
Hae Won Lee |
|
232 |
INTRO
로그인
회원가입안내
이메일 무단 수집 거부